These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 37337226)

  • 1. Cross-reactive immune responses to monkeypox virus induced by MVA vaccination in mice.
    Gao F; He C; Liu M; Yuan P; Tian S; Zheng M; Zhang L; Zhou X; Xu F; Luo J; Li X
    Virol J; 2023 Jun; 20(1):126. PubMed ID: 37337226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus.
    Chiuppesi F; Zaia JA; Gutierrez-Franco MA; Ortega-Francisco S; Ly M; Kha M; Kim T; Dempsey S; Kar S; Grifoni A; Sette A; Wussow F; Diamond DJ
    Commun Med (Lond); 2024 Feb; 4(1):19. PubMed ID: 38366141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early evaluation of the safety, reactogenicity, and immune response after a single dose of modified vaccinia Ankara-Bavaria Nordic vaccine against mpox in children: a national outbreak response.
    Ladhani SN; Dowell AC; Jones S; Hicks B; Rowe C; Begum J; Wailblinger D; Wright J; Owens S; Pickering A; Shilltoe B; McMaster P; Whittaker E; Zuo J; Powell A; Amirthalingam G; Mandal S; Lopez-Bernal J; Ramsay ME; Kissane N; Bell M; Watson H; Ho D; Hallis B; Otter A; Moss P; Cohen J
    Lancet Infect Dis; 2023 Sep; 23(9):1042-1050. PubMed ID: 37336224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unexpectedly higher levels of anti-orthopoxvirus neutralizing antibodies are observed among gay men than general adult population.
    Feng Y; Zhang Y; Liu S; Guo M; Huang H; Guo C; Wang W; Zhang W; Tang H; Wan Y
    BMC Med; 2023 May; 21(1):183. PubMed ID: 37189197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals.
    Zaeck LM; Lamers MM; Verstrepen BE; Bestebroer TM; van Royen ME; Götz H; Shamier MC; van Leeuwen LPM; Schmitz KS; Alblas K; van Efferen S; Bogers S; Scherbeijn S; Rimmelzwaan GF; van Gorp ECM; Koopmans MPG; Haagmans BL; GeurtsvanKessel CH; de Vries RD
    Nat Med; 2023 Jan; 29(1):270-278. PubMed ID: 36257333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals.
    Hubert M; Guivel-Benhassine F; Bruel T; Porrot F; Planas D; Vanhomwegen J; Wiedemann A; Burrel S; Marot S; Palich R; Monsel G; Diombera H; Gallien S; Lopez-Zaragoza JL; Vindrios W; Taieb F; Fernandes-Pellerin S; Delhaye M; Laude H; Arowas L; Ungeheuer MN; Hocqueloux L; Pourcher V; Prazuck T; Marcelin AG; Lelièvre JD; Batéjat C; Lévy Y; Manuguerra JC; Schwartz O
    Cell Host Microbe; 2023 Jun; 31(6):937-948.e4. PubMed ID: 37196656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serosurvey of Immunity to Monkeypox (Mpox) Virus Antigens in People Living with HIV in South Florida.
    Kupritz J; Pahwa S; Pallikkuth S
    Pathogens; 2023 Nov; 12(11):. PubMed ID: 38003819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of Congo.
    Priyamvada L; Carson WC; Ortega E; Navarra T; Tran S; Smith TG; Pukuta E; Muyamuna E; Kabamba J; Nguete BU; Likafi T; Kokola G; Lushima RS; Tamfum JM; Okitolonda EW; Kaba DK; Monroe BP; McCollum AM; Petersen BW; Satheshkumar PS; Townsend MB
    Vaccine; 2022 Nov; 40(50):7321-7327. PubMed ID: 36344361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mpox multi-antigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challenge.
    Zeng J; Li Y; Jiang L; Luo L; Wang Y; Wang H; Han X; Zhao J; Gu G; Fang M; Huang Q; Yan J
    Emerg Microbes Infect; 2023 Dec; 12(1):2204151. PubMed ID: 37070521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease.
    Zuiani A; Dulberger CL; De Silva NS; Marquette M; Lu YJ; Palowitch GM; Dokic A; Sanchez-Velazquez R; Schlatterer K; Sarkar S; Kar S; Chawla B; Galeev A; Lindemann C; Rothenberg DA; Diao H; Walls AC; Addona TA; Mensa F; Vogel AB; Stuart LM; van der Most R; Srouji JR; Türeci Ö; Gaynor RB; Şahin U; Poran A
    Cell; 2024 Mar; 187(6):1363-1373.e12. PubMed ID: 38366591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing the acute antibody response of monkeypox and MVA-BN vaccine following an Australian outbreak.
    Asquith W; Hueston L; Dwyer D; Kok J; Ko D; Fennel M; Rockett R; Rai NJ; Li Y; Sriramoju S; Sutor A; O'Sullivan M
    J Med Virol; 2024 Jan; 96(1):e29407. PubMed ID: 38240403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Multi-Epitope Universal mRNA Vaccine Candidate for Monkeypox, Smallpox, and Vaccinia Viruses: Design and In Silico Analyses.
    Rcheulishvili N; Mao J; Papukashvili D; Feng S; Liu C; Yang X; Lin J; He Y; Wang PG
    Viruses; 2023 May; 15(5):. PubMed ID: 37243206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining antigen targets to dissect vaccinia virus and monkeypox virus-specific T cell responses in humans.
    Grifoni A; Zhang Y; Tarke A; Sidney J; Rubiro P; Reina-Campos M; Filaci G; Dan JM; Scheuermann RH; Sette A
    Cell Host Microbe; 2022 Dec; 30(12):1662-1670.e4. PubMed ID: 36463861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge.
    Nigam P; Earl PL; Americo JL; Sharma S; Wyatt LS; Edghill-Spano Y; Chennareddi LS; Silvera P; Moss B; Robinson HL; Amara RR
    Virology; 2007 Sep; 366(1):73-83. PubMed ID: 17507071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three neutralizing mAbs induced by MPXV A29L protein recognizing different epitopes act synergistically against orthopoxvirus.
    Li M; Ren Z; Wang Y; Jiang Y; Yang M; Li D; Chen J; Liang Z; Lin Y; Zeng Z; Xu R; Wang Y; Zhu L; Xiao W; Wu Q; Zhang B; Wan C; Yang Y; Wu B; Peng J; Zhao W; Shen C
    Emerg Microbes Infect; 2023 Dec; 12(2):2223669. PubMed ID: 37288876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design of a 'two-in-one' immunogen DAM drives potent immune response against mpox virus.
    Wang H; Yin P; Zheng T; Qin L; Li S; Han P; Qu X; Wen J; Ding H; Wu J; Kong T; Gao Z; Hu S; Zhao X; Cao X; Fang M; Qi J; Xi JJ; Duan K; Yang X; Zhang Z; Wang Q; Tan W; Gao GF
    Nat Immunol; 2024 Feb; 25(2):307-315. PubMed ID: 38182667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monkeypox Virus Cross-Neutralizing Antibodies in Clinical Trial Participants Vaccinated With Modified Vaccinia Virus Ankara Encoding Middle East Respiratory Syndrome-Coronavirus Spike Protein.
    Raadsen MP; Dahlke C; Fathi A; Lamers MM; van den Doel P; Zaeck LM; van Royen ME; de Bruin E; Sikkema R; Koopmans M; van Gorp ECM; Sutter G; de Vries RD; Addo MM; Haagmans BL
    J Infect Dis; 2023 Aug; 228(5):586-590. PubMed ID: 36857443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified vaccinia virus Ankara encoding influenza virus hemagglutinin induces heterosubtypic immunity in macaques.
    Florek KR; Weinfurter JT; Jegaskanda S; Brewoo JN; Powell TD; Young GR; Das SC; Hatta M; Broman KW; Hungnes O; Dudman SG; Kawaoka Y; Kent SJ; Stinchcomb DT; Osorio JE; Friedrich TC
    J Virol; 2014 Nov; 88(22):13418-28. PubMed ID: 25210172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge.
    Freyn AW; Atyeo C; Earl PL; Americo JL; Chuang GY; Natarajan H; Frey TR; Gall JG; Moliva JI; Hunegnaw R; Asthagiri Arunkumar G; Ogega CO; Nasir A; Santos G; Levin RH; Meni A; Jorquera PA; Bennett H; Johnson JA; Durney MA; Stewart-Jones G; Hooper JW; Colpitts TM; Alter G; Sullivan NJ; Carfi A; Moss B
    Sci Transl Med; 2023 Oct; 15(716):eadg3540. PubMed ID: 37792954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV.
    Marín MQ; Pérez P; Ljungberg K; Sorzano CÓS; Gómez CE; Liljeström P; Esteban M; García-Arriaza J
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30674625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.